Novartis AG
Enhanced antigen presenting ability of RNA CAR T cells by co-introduction of costimulatory molecules

Abstract:

The invention provides T cells comprising nucleic acid sequence encoding a chimeric antigen receptor and a nucleic acid sequence encoding an enhancer of T cell priming, compositions including the T cells, and methods of using the T cells to treat diseases associated with the expression of disease-associated antigens.